Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice
Viraj Mane,1 Silvia Muro1, 21Institute for Bioscience and Biotechnology Research, 2Fischell Department of Bioengineering, University of Maryland, College Park, MD, USAAbstract: Drug delivery to the gastrointestinal (GI) tract is key for improving treatment of GI maladies, developing oral vaccines, a...
Enregistré dans:
Auteurs principaux: | Mane V, Muro S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4b57a4be86ea428d9090a6ef26f5b56b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy
par: Wang X, et autres
Publié: (2020) -
Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract
par: Sabrina I. Green, et autres
Publié: (2021) -
An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.
par: Stephanie Traub, et autres
Publié: (2013) -
Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
par: Aditya Rayasam, et autres
Publié: (2021) -
Are the solutions to radiotherapy side effects on the gastrointestinal tract right at our doorstep?
par: Christoph Berliner
Publié: (2021)